Rite Aid's March results spurred a 3% lift in its share price Thursday morning.
Amneal Pharmaceuticals will acquire Actavis Australia's generic pharmaceutical business. Financial terms of the agreement were not disclosed.
Teva Pharmaceutical Industries and Auspex Pharmaceuticals announced an agreement under which Teva will acquire Auspex in a deal valued at $3.2 billion.
The two companies will merge to create The Kraft Heinz Company, resulting in a portfolio that will make the newly formed entity a food-and-beverage powerhouse.
Diplomat Pharmacy commences follow-on public offering of 7.4 million shares of its common stock.
Rite Aid will fund in part the cash portion of its acquisition of EnvisionRx through the offering of $1.8 billion in senior unsecured notes due 2023.
Par Pharmaceutical Holdings last week announced that it filed a statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock.
Ulta Beauty wrapped up 2014 with "an excellent fourth quarter," which marked the company's first billion dollar sales quarter.
An Altarum report found that national health spending increased 5.7% in January 2015 vs. January 2014.
Loblaw aims to create better access to fresh food, wellness solutions and e-commerce with $1.2B investment.